Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Dominant effects of Δ40p53 on p53 function and melanoma cell fate
Rie Takahashi
,
Svetomir N. Markovic
, Heidi J. Scrable
Hematology
Laboratory Medicine and Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dominant effects of Δ40p53 on p53 function and melanoma cell fate'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cell Fate
100%
Melanoma Cells
100%
Dominant Effect
100%
Function Cell
100%
In Cancer
66%
Cancer Cells
66%
Apoptosis
66%
Genetic Modification
33%
Melanoma
33%
Tumor
33%
Non-cancer
33%
Cell Cycle Arrest
33%
Cell Death
33%
Tumor Protein p53 (TP53)
33%
Ligand-binding Domain
33%
Transactivation
33%
TP53 mutation
33%
Tumor Suppression
33%
Lentivirus
33%
Promoter Occupancy
33%
Death Domain
33%
Murine Double Minute 2 (MDM2)
33%
Significant Level
33%
P53 Gene
33%
N-terminal Amino Acids
33%
Cyclin-dependent Kinase Inhibitor p21
33%
P53 Activity
33%
Heterotetramer
33%
P53 Isoforms
33%
P53 Target Gene
33%
Domain-oriented
33%
Biochemistry, Genetics and Molecular Biology
P53
100%
Cell Fate
100%
Isoform
50%
Programmed Cell Death
20%
Cancer Cell
10%
Amino Acids
10%
N-Terminus
10%
Promoter Region
10%
Cell Cycle Arrest
10%
Cell Death
10%
Transcription
10%
Binding Domain
10%
Transactivation
10%
P21
10%
Cyclin-Dependent Kinase
10%
Cell Cycle Checkpoint
10%
Lentivirus
10%
Death Domain
10%
Mdm2
10%
Heterotetramer
10%
Genomics
10%
Neuroscience
Cell Fate
100%
P53
100%
TP53
30%
Programmed Cell Death
20%
Amino Terminal Sequence
10%
Cell Death
10%
Cell Cycle Arrest
10%
Amino Acid
10%
Promoter Region
10%
Cell Cycle Checkpoint
10%
Death Domain
10%
Transactivation
10%
Cyclin Dependent Kinase Inhibitor 1A
10%
Genetics
10%